Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

GLP-1 meds are are highly effective at treating diabetes, obesity and other conditions. But when people stop using them, the ...

Diarrhea is a common side effect of Ozempic due to the medication’s effect on the digestive system, which slows nutrient absorption. Dietary adjustments, such as eating smaller meals and avoiding ...

GLP-1 drugs like Ozempic and Mounjaro have significant health benefits for type 1 diabetes, including weight loss, despite ...

Treatment with semaglutide has been shown to reduce the total number of hospital admissions and the duration of stays in patients with established cardiovascular disease (CVD) and overweight or ...

Industry Trends and Global Forecasts, Till 2035" report has been added to ResearchAndMarkets.com's offering. The global GLP-1 market is estimated to grow from USD 62.2 billion in the current year to ...

When people who are overweight and obese stopped taking their weight-loss medications they regained weight faster than those ...

People who stop taking GLP-1 drugs such as Ozempic and Wegovy for weight loss are projected to regain their shed pounds ...

The new pill will cost $25 or less in copay per month if covered by insurance and between $149 and $299 per month for self-pay.

How to lose weight in 2026 with the new Wegovy pill. Also in this month’s Your Health column: Is the super flu a real thing; ...

Explore the most influential drug approvals of 2025, highlighting FDA-cleared therapies that impact public health and clinical care.

People who stop taking weight-loss jabs such as Wegovy regain pounds much faster than those who halt exercising and dieting, ...